Editorial: RNA recognition landscapes and anticancer drug targeting

doi:10.3389/fonc.2023.1222883

Editorial

. 2023 Jun 19:13:1222883.

doi: 10.3389/fonc.2023.1222883. eCollection 2023.

Editorial: RNA recognition landscapes and anticancer drug targeting

Erica Salvati¹, Anna Lewinska², Erik Dassi³, Maciej Wnuk², Vito G D'Agostino⁴

Affiliations

¹ Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
² Institute of Biotechnology, College of Natural Sciences, University of Rzeszow, Rzeszow, Poland.
³ Laboratory of RNA Regulatory Networks, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
⁴ Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.

PMID: 37404766
PMCID: PMC10315894
DOI: 10.3389/fonc.2023.1222883

Editorial

Editorial: RNA recognition landscapes and anticancer drug targeting

Erica Salvati et al. Front Oncol. 2023.

. 2023 Jun 19:13:1222883.

doi: 10.3389/fonc.2023.1222883. eCollection 2023.

Authors

Erica Salvati¹, Anna Lewinska², Erik Dassi³, Maciej Wnuk², Vito G D'Agostino⁴

Affiliations

¹ Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
² Institute of Biotechnology, College of Natural Sciences, University of Rzeszow, Rzeszow, Poland.
³ Laboratory of RNA Regulatory Networks, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.
⁴ Laboratory of Biotechnology and Nanomedicine, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.

PMID: 37404766
PMCID: PMC10315894
DOI: 10.3389/fonc.2023.1222883

No abstract available

Keywords: RNA; RNA-binding proteins; anti-cancer; anti-inflammatory; drug; mechanism of action (MOA); post-transcriptional control.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

Editorial on the Research Topic RNA recognition landscapes and anticancer drug targeting

References

1. Moore MJ. From birth to death: the complex lives of eukaryotic mRNAs. Science (2005) 309:1514–8. doi: 10.1126/science.1111443 - DOI - PubMed
1. Nag S, Goswami B, Das Mandal S, Ray PS. Cooperation and competition by RNA-binding proteins in cancer. Semin Cancer Biol (2022) 86:286–97. doi: 10.1016/j.semcancer.2022.02.023 - DOI - PubMed
1. Dassi E. Handshakes and fights: the regulatory interplay of RNA-binding proteins. Front Mol Biosci (2017) 4:67. doi: 10.3389/fmolb.2017.00067 - DOI - PMC - PubMed
1. Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, et al. . miRNAs as novel immunoregulators in cancer. Semin Cell Dev Biol (2022) 124:3–14. doi: 10.1016/j.semcdb.2021.04.013 - DOI - PubMed
1. Budakoti M, Panwar AS, Molpa D, Singh RK, Büsselberg D, Mishra AP, et al. . Micro-RNA: the darkhorse of cancer. Cell Signal (2021) 83:109995. doi: 10.1016/j.cellsig.2021.109995 - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

[1] Moore MJ. From birth to death: the complex lives of eukaryotic mRNAs. Science (2005) 309:1514–8. doi: 10.1126/science.1111443 - DOI - PubMed

[2] Moore MJ. From birth to death: the complex lives of eukaryotic mRNAs. Science (2005) 309:1514–8. doi: 10.1126/science.1111443 - DOI - PubMed

[3] Nag S, Goswami B, Das Mandal S, Ray PS. Cooperation and competition by RNA-binding proteins in cancer. Semin Cancer Biol (2022) 86:286–97. doi: 10.1016/j.semcancer.2022.02.023 - DOI - PubMed

[4] Nag S, Goswami B, Das Mandal S, Ray PS. Cooperation and competition by RNA-binding proteins in cancer. Semin Cancer Biol (2022) 86:286–97. doi: 10.1016/j.semcancer.2022.02.023 - DOI - PubMed

[5] Dassi E. Handshakes and fights: the regulatory interplay of RNA-binding proteins. Front Mol Biosci (2017) 4:67. doi: 10.3389/fmolb.2017.00067 - DOI - PMC - PubMed

[6] Dassi E. Handshakes and fights: the regulatory interplay of RNA-binding proteins. Front Mol Biosci (2017) 4:67. doi: 10.3389/fmolb.2017.00067 - DOI - PMC - PubMed

[7] Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, et al. . miRNAs as novel immunoregulators in cancer. Semin Cell Dev Biol (2022) 124:3–14. doi: 10.1016/j.semcdb.2021.04.013 - DOI - PubMed

[8] Lone SN, Bhat AA, Wani NA, Karedath T, Hashem S, Nisar S, et al. . miRNAs as novel immunoregulators in cancer. Semin Cell Dev Biol (2022) 124:3–14. doi: 10.1016/j.semcdb.2021.04.013 - DOI - PubMed

[9] Budakoti M, Panwar AS, Molpa D, Singh RK, Büsselberg D, Mishra AP, et al. . Micro-RNA: the darkhorse of cancer. Cell Signal (2021) 83:109995. doi: 10.1016/j.cellsig.2021.109995 - DOI - PubMed

[10] Budakoti M, Panwar AS, Molpa D, Singh RK, Büsselberg D, Mishra AP, et al. . Micro-RNA: the darkhorse of cancer. Cell Signal (2021) 83:109995. doi: 10.1016/j.cellsig.2021.109995 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: RNA recognition landscapes and anticancer drug targeting

Affiliations

Editorial: RNA recognition landscapes and anticancer drug targeting

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources